Skip to main content

Table 4 Factors associated with the occurrence of CAPA (univariate and multivariate analysis)

From: Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves

 

No CAPA (n = 415)

CAPA (n = 22)

p-value

Multivariate OR (95%IC), p-value

MV, days, median (Q1;Q3)

9 (5;19)

21.5 (10.3;36.8)

0.0027

 

RRT, n (%)

37 (9%)

9 (41%)

0.0023

1,58 (0.99–2.46. p = 0.046)

VAP associated, n (%)

39/260 (15%)

8/22 (36%)

0.0136

2.92 (0.98–8.30. P = 0.046)

Mortality, n (%)

 In ICU

38 (9%)

8 (36%)

0.0114

 

 In hospital

51 (12%)

9 (41%)

0.0238

 

LOS, days, median (Q1;Q3)

 In ICU

12 (7;21)

21.5 (10.3;31.8)

0.0062

 

 In Hospital

24 (16.8;40)

51 (22.3;69.5)

0.0028

 
  1. MV mechanical ventilation, CAPA Covid associated pulmonary aspergillosis, RRT renal replacement therapy, VAP ventilated associated pneumonia, LOS length of stay